Inhaled products
The British Pharmacopoeia (BP) consulted on the BP Commission’s requirements for new and revised monographs for inhalation products. Following the consultation, stakeholder comments were considered by the BP’s Expert Advisory Group for Pharmacy (EAG PCY) and the future strategy endorsed by the BP Commission.
The consultation closed in July 2014 and the public response published in March 2015.